Loading...
Value based pricing, research and development, and patient access schemes. Will the United Kingdom get it right or wrong?
The National Health Service (NHS) should reward innovation it values. This will enable the NHS and the United Kingdom (UK) economy to benefit and impact positively on the Research and Development (R&D) decision making of companies. The National Institute for Health and Clinical Excellence (NICE)...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Blackwell Science Inc
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2949908/ https://ncbi.nlm.nih.gov/pubmed/20716236 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2010.03740.x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|